Navigation Links
Actavis Full Year 2012 Net Revenue Increases 29% to $5.91 Billion
Date:2/19/2013

shareholders$
28.0$
94.8$
97.3$
260.9Plus:Interest expense54.612.7116.781.8Interest income(1.2)(0.5)(2.5)(2.1)Provision for income taxes88.261.5146.8196.9Depreciation (includes accelerated depreciation)36.821.397.593.6Amortization(1)148.4151.5481.9355.5EBITDA354.8341.3937.7986.6Adjusted for:Global supply chain initiative8.40.214.411.0Acquisition and licensing charges77.814.9294.137.7Non-cash impairment charges29.918.7149.544.3Non-recurring (gains) losses(119.3)(0.9)(134.6)(13.2)Legal settlements27.35.087.75.0Accretion (income) expense-(0.1)0.4(0.3)Share-based compensation14.114.348.739.8Adjusted EBITDA$
393.0$
393.4$
,397.9$
,110.9(1) Includes amortization of excess purchase price on equity method investment.The following table presents a reconciliation of forecasted net income for the twelve months ending December 31, 2013 to non-GAAP net income and non-GAAP earnings per diluted share:

 Table 6Actavis, Inc.Reconciliation Table - Forecasted Non-GAAP Earnings Per Diluted Share(Unaudited; in millions except per share amounts)Forecast for Twelve Months
Ending December 31, 2013LowHighGAAP to Non-GAAP net income calculationGAAP net income$
440$
490Adjusted for:Amortization 625630Global supply chain initiative3535Acquisition and licensing charges 150150Interest accretion on contingent liability 77Non-cash impairment charges Non-recurring (gains) losses Income taxes on items above(222)(224)Adjusted Non-GAAP net income1,0351,088Diluted earnings per shareDiluted earnings per share - GAAP $
3.27$
3.65Diluted earnings per share - Non-GAAP$
7.70$
8.10Diluted weighted average common shares outstanding*134.4134.4*Includes the maximum of 5.5 million shares potentially issuable to the former shareholders of the Actavis Group, subject to final determination of the legacy Actavis business' 2012 Cash EBITDA as calculated in the Actavis acquisit
'/>"/>

SOURCE Actavis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. Watson to Acquire Actavis Group for EUR4.25 Billion
2. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
3. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
4. Watson and Actavis Receive FTC Second Request
5. Watson Announces New Name -- Actavis -- for Global Operations
6. Watson Pharmaceuticals, Inc. is Now Actavis, Inc.
7. Actavis, Inc. to Host Fourth Quarter 2012 Earnings Conference Call and Webcast
8. Actavis, Inc. to Present at the RBC Capital Markets Healthcare Conference
9. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
10. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
11. Aethlon Medical Note: Fiscal Year Revenue Guidance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 ... clinical research unit with a worldwide reputation for ... its frequent publications in peer reviewed medical journals. ... stakeholders and regulators in discussions about rules for ...      (Logo: http://photos.prnewswire.com/prnh/20150522/745125) , Clinical ...
(Date:5/21/2015)... , May 21, 2015 ... has announced the addition of the ... (Ankle Replacement, Digit Replacement, Elbow Replacement, Hip ... to 2019" report to their offering. ... knee replacement was valued at $4,470.9 million ...
(Date:5/21/2015)... DUBLIN , May 21, 2015 ... has announced the addition of the "Market ... and Europe" report to their offering. ,     ... analysis of the respiratory imaging diagnostics market in ... Europe . The service provides ...
Breaking Medicine Technology:North American Joint Reconstruction Market 2015-2019 - Zimmer Holdings, DePuy Synthes Companies, Stryker, Biomet & Smith & Nephew Dominates the $4.4 Billion Market 2United States and Europe Respiratory Diagnostics Market Assessment 2015 2
... 2011 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: ... devices worldwide, announced today its selected unaudited financial results for ... Highlights for Second Quarter 2011 ... 21.2% over the second quarter of 2010. Robust ...
... Pharmaceutical Company ("the Company," "K-V") (NYSE: KVa/KVb) today announced ... of assets of Nesher Pharmaceuticals, Inc. ("Nesher"), the Company,s ... assets to Zydus Pharmaceuticals (USA), Inc and Zynesher Pharmaceuticals ... sales price for the transaction is $60 million (subject ...
Cached Medicine Technology:Mindray Announces Second Quarter 2011 Financial Results 2Mindray Announces Second Quarter 2011 Financial Results 3Mindray Announces Second Quarter 2011 Financial Results 4Mindray Announces Second Quarter 2011 Financial Results 5Mindray Announces Second Quarter 2011 Financial Results 6Mindray Announces Second Quarter 2011 Financial Results 7Mindray Announces Second Quarter 2011 Financial Results 8Mindray Announces Second Quarter 2011 Financial Results 9Mindray Announces Second Quarter 2011 Financial Results 10Mindray Announces Second Quarter 2011 Financial Results 11Mindray Announces Second Quarter 2011 Financial Results 12Mindray Announces Second Quarter 2011 Financial Results 13Mindray Announces Second Quarter 2011 Financial Results 14Mindray Announces Second Quarter 2011 Financial Results 15Mindray Announces Second Quarter 2011 Financial Results 16Mindray Announces Second Quarter 2011 Financial Results 17K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 2K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 3K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 4K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 5K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 6K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 7K-V Pharmaceutical Company Announces the Completion of the Sale of Nesher Pharmaceuticals, Inc. its Generic Pharmaceutical Business 8
(Date:5/24/2015)... Scientists with Cardno ChemRisk, a scientific ... compliance issues that may have raised the risk of ... just posted an article on the research. Click ... found airborne asbestos levels well above OSHA safety guidelines ... 2011. , “Asbestos compliance sampling data associated with the ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ProPin is ... Final Cut Pro X. Utilize ProPin to pin point locations ... given scene. , ProPin allows users to choose from ... in FCPX. With on-screen controls, video editors can easily manipulate ... to pin and mark with absolute ease. , Using ProPin is ...
(Date:5/24/2015)... (PRWEB) May 24, 2015 ... System CEO - The students ... honored at the fourth annual A ... 15 at Geneva National in Lake ... ,     -Badger High School,         Jonathan Alfonso, ...
(Date:5/23/2015)... D.C. (PRWEB) May 23, 2015 On ... of powers of a youngster's yogic power learned through ... Sri Nithyananda Swami in Bangalore, India. , Yogamaatha, a ... more than 50 high profile professionals attending the 2015 ... by reading fluently -- blindfolded. , In a ...
(Date:5/23/2015)... On Wednesday, May 20, 2015, CareFirst ... been the target of a sophisticated cyberattack,” and that ... ongoing Information Technology (IT) security efforts in the wake ... most notable attack on health insurers was reported in ... second largest health insurer, revealed that they had suffered ...
Breaking Medicine News(10 mins):Health News:New Analysis Finds Too Many Employers Ignored OSHA Asbestos Guidelines, According to Surviving Mesothelioma 2Health News:Developers at Pixel Film Studios Release ProPin for Final Cut Pro X. 2Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 2Health News:Nine-Year-Old Reads Blindfolded at Business Advocacy Summit 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 2Health News:One Headline Making Cyber Attack Sparks Discovery of Another 3Health News:One Headline Making Cyber Attack Sparks Discovery of Another 4
... November 6 - Elsevier Signs Agreement ... that major global healthcare company, Bayer,HealthCare AG, headquartered ... EMBASE Classic. Available in electronic format for,the first ... database,drawn from 43 Excerpta Medica Abstract Journals published ...
... book geared to genetic blueprints from Elite Books, TUCSON, ... gene. It,plays a key role in the development of Alzheimer,s ... And it is greatly affected,by diet. In her seminal ... Weight, Heart and Alzheimer,s Using the Body,s Own Genes,(Elite, Hardcover, ...
... Former Congressman,Henry J. Hyde was among eight people ... the Presidential Medal of Freedom. President Bush said,that ... of Mr. Hyde,s 32 years,of public service., ... Rehabilitation,Hospital where he is currently receiving medical rehabilitation ...
... 5 Epeius Biotechnologies,Corporation announced today that the company ... lead product with the opening of a Phase II,Registration ... the accelerated approval of Rexin-G for the treatment of ... in the Philippines, Epeius,opened a number of Phase I/II ...
... QED International Associates Inc,administrator for the HealthShares(TM) ... today announced that effective at the,opening of trading ... BSMD ) will replace Kyphon INC. (Nasdaq: ... The Corin Group (LSE: CRG.L) will,replace KYPH in ...
... 5 Hooper Holmes,Inc. (AMEX: HH ) today announced ... Inc. (Nasdaq: NABI ), has been,reappointed to the Company,s ... Board from 2005 to 2006. He replaces Paul Kolacki who,retired ... respect Les, and we are pleased to welcome him back ...
Cached Medicine News:Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 2Health News:EMBASE Classic Makes Inroads into Pharmaceutical Industry 3Health News:Groundbreaking Apo E Gene Diet Linked to Alzheimer's Disease and Heart Disease Prevention 2Health News:Former Congressman Hyde Awarded Presidential Medal of Freedom While Receiving Medical Rehabilitation at Marianjoy 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 2Health News:FDA Approves the Opening of a Phase II Registration Protocol Using REXIN-G(R) for Osteosarcoma in California U.S.A. 3Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 2Health News:QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cardio Devices, and the HealthShares(TM) Orthopedic Repair Indexes 3Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 2Health News:Hooper Holmes Appoints Leslie Hudson, PhD, to Board of Directors 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: